Indications and Important Safety Information
Indications and Usage
LUZU (luliconazole) Cream, 1% is indicated for the topical treatment of interdigital tinea pedis, tinea cruris, and tinea corporis caused by the organisms Trichophyton rubrum and Epidermophyton floccosum in patients 18 years of age and older.
Important Safety Information
LUZU is indicated for topical use only and is not indicated for ophthalmic, oral or intravaginal use.
LUZU should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Caution should be exercised when LUZU is prescribed for nursing mothers.
The most common adverse reactions in clinical trials were application site reactions, which occurred in less than 1% of subjects in both LUZU and vehicle arms. Most adverse reactions were mild in severity.
*Offer valid for commercially insured patients whose insurance covers LUZU only. Commercially insured and cash-paying patients whose insurance does not cover LUZU will pay more. This or any other offer is not valid for prescriptions reimbursed in whole or in part by Medicaid, Medicare, or any other federal or state programs (including VA, DOD, Tricare, and any state prescription drug programs). Please see coupon for full eligibility terms and conditions.
®/TMs are trademarks of Valeant Pharmaceuticals International, Inc. or its affiliates. All other product or brand names are trademarks of their respective owners.
©2016 Valeant Pharmaceuticals North America LLC. LUZ.0037.USA.16